| UGT2B7 |
Homo sapiens |
|
UGT2B7 is differentially expressed in 21 experiments [16 up/21 dn]: 13 organism parts: kidney [2 up/0 dn], peripheral blood [0 up/1 dn], ...; 5 disease states: Burkitt's lymphoma [1 up/0 dn], KSHV latent infection [0 up/1 dn], ...; 2 cell types, 1 cell lines, 3 compound treatments and 5 other conditions. |
| UGT2B7, UGTB2B9 |
|
(Compare orthologs)
|
|
|
| UDP-glucuronosyl/UDP-glucosyltransferase |
|
|
| endoplasmic reticulum, glucuronosyltransferase activity, integral to membrane, metabolic process, transferase activity, transferring hexosyl groups |
|
|
|
P16662
Q5QKR3
Q99912
Q9HCT7
|
|
|
|
ENSG00000171234
|
|
|
| Factor Value |
Factor |
Up/Down |
Legend: - number of studies the gene is up/down in
|
|
Kidney
|
Organism part |
|
|
None
|
Compound treatment |
|
|
Peripheral blood
|
Organism part |
|
|
Liver
|
Organism part |
|
|
Methotrexate
|
Compound treatment |
|
|
Affymetrix Labeling
|
Protocol type |
|
|
Burkitt's lymphoma
|
Disease state |
|
|
Brain
|
Organism part |
|
|
Spinal cord
|
Organism part |
|
|
CodeLink Labeling
|
Protocol type |
|
|
Duodenum
|
Organism part |
|
|
Bone marrow
|
Organism part |
|
|
Enzo Labeling
|
Protocol type |
|
|
Skeletal muscle
|
Organism part |
|
|
Spleen
|
Organism part |
|
|
PT1
|
Disease staging |
|
|
Lung
|
Organism part |
|
|
Pancreas
|
Organism part |
|
|
Dendritic cell
|
Cell type |
|
|
Macrophage
|
Cell type |
|
|
T3aNxMx
|
Disease staging |
|
|
KSHV latent infection
|
Disease state |
|
|
Acute lymphocytic leukemia
|
Disease state |
|
|
Neo-resistant
|
Genotype |
|
|
TIVE
|
Cell line |
|
|
Endometrioid carcinoma
|
Disease state |
|
|
Granulocyte macrophage-colony ...
|
Compound treatment |
|
|
Normal
|
Disease state |
|
|
T3bN2M0
|
Disease staging |
|
|
Polysome associated RNA
|
Material type |
|
|
Total_RNA
|
Material type |
|
|
Heart
|
Organism part |
|
|
Thymus
|
Organism part |
|
|
G1
|
Tumor grading |
|
|
Wild_type
|
Genotype |
|
|
|
|
|
Processing time: 0.032 secs.